Inonza 1mg Injection
Marketer
Pfizer Ltd
Salt Composition
Inotuzumab Ozogamacin (1mg)
Overview Inonza 1mg Injection
Inonza 1mg Injection, a CD22-targeted antibody-drug conjugate (ADC), treats adults with recurrent or treatment-resistant B-cell precursor acute lymphoblastic leukemia (ALL). Administered intravenously by a healthcare professional, the Inonza 1mg dose is individualized and may vary. Strictly adhere to your physician's prescribed regimen; incorrect usage or exceeding the recommended dose can lead to severe adverse events. Therapeutic benefits might not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include reduced blood cell counts (red blood cells, white blood cells, and platelets), infections, tiredness, bleeding, fever, nausea, headache, elevated liver enzymes, and stomach pain. Report any concerning symptoms to your doctor; management strategies may be available. Disclose any history of bleeding disorders, cardiac or hepatic disease, prior radiation therapy, or infections. Numerous drug interactions are possible; fully inform your doctor of all medications you are taking. Immediately report unusual bruising or bleeding, dark or bloody stools, and sore throat. This medication lowers blood cell counts, increasing infection risk. Regular blood tests monitoring blood cell levels, kidney, liver, and heart function are essential. Effective contraception for both men and women is crucial throughout treatment to prevent pregnancy.
Uses of Inonza 1mg Injection
Rapid-onset lymphocytic leukemia
Major Benefits of Inonza 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Inonza 1mg Injection:
- Low blood platelets
- Decreased white blood cell count (neutrophils)
- Infection
- Anemia (low number of red blood cells)
- Decreased white blood cell count (lymphocytes)
- Fatigue
- Hemorrhage
- Fever
- Nausea
- Headache
- Febrile neutropenia
- Increased transaminase level in blood
- Abdominal pain
- Increased gamma-glutamyltransferase
- Increased bilirubin in the blood
How to use Inonza 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Inonza 1mg Injection works:
Inotuzumab Ozogamicin 1mg Injection (Inonza) is an antineoplastic medication indicated for adult patients with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL). It functions by binding to the CD22 antigen on immature B-lymphocytes, thereby inhibiting tumor cell proliferation. Treatment with this injection aims to facilitate hematologic recovery and induce complete remission.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Inonza 1mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Inonza 1mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Inonza 1mg Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of Inonza 1mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Inonza 1mg Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverSAFE IF PRESCRIBED
Inonza 1mg Injection poses no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Inonza 1mg Injection :
NA
Facts to Know About Inonza 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Short chains of amino acids |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently